FDA Inspection 1166753 — Novant Health New Hanover Regional Medical Center
The FDA completed an inspection of Novant Health New Hanover Regional Medical Center on Mar 22, 2022 in Wilmington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 22, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wilmington, NC (United States)